Clinical Trials Browser

Phase 1 × tosedostat × Other hematologic neoplasm × Clear all

NCT01636609 2020-04-13

Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute